Company

Renalytix

Biotechnology Research New York, United States 53 employees RNLX

Employees: 53
Contacts: 2
Emails: 2
Phones: 2

renalytix.com LinkedIn

Renalytix Overview

Headquarters: New York, United States
Website: renalytix.com
Industry: Biotechnology Research
Employees: 53
Stock Symbol: RNLX
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

to 700

About Renalytix

Renalytix (LSE: RENX) (NASDAQ: RNLX) is the founder and global leader in the new field of bioprognosis™ for kidney health. We’ve engineered a proprietary solution that successfully enables early-stage, progression risk assessment when it counts the most. Renalytix. Right here, until kidney disease isn’t.™

Renalytix Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 2; 50.0% coverage

Renalytix Org Chart

Sample employees and titles

Name	Title	Location	Contact
Elise Wilfinger	Chief Strategy Officer, Chief Marketing Officer, Brand Architect, Growth Accelerator, Early-stage/next-stage Strategist, AI, B2b2c, GTM		View
Jed Fulk	Vice President of Sales	Raleigh, North Carolina, United States	Email Phone
Erik Lium	Chief Commercial Innovation Officer, Mount Sinai Health System; President, Mount Sinai Innovation Partners	New York, United States	Email Phone
Joe Fraas, Mba	Sales Director I Sales Leadership I Commercial Leader		View